© 2020 MJH Life Sciences and HCPLive. All rights reserved.
August 10, 2020
Results of ANDHI provide additional support on the safety and efficacy of benralizumab for patients with asthma.
August 08, 2020
Dupilumab significantly reduces exacerbation rates in patients with asthma compared to standard of care.
In a study presented virtually at ATS 2020, investigators find 15 mg of the study drug resulted in a 43% decrease in FeNO.
August 07, 2020
A new case study assesses biopsy and autopsy tissues to characterize pathological patterns in suspected EVALI cases .
In a study presented at ATS 2020, investigators test 3 different dosing regimens of tezepelumab in asthma patients with both high and low levels of IL-5 and IL-13.
August 06, 2020
A one-time intramuscular dose of the investigative drug was linked to reduced medical attention and hospitalizations related to RSV.
August 05, 2020
New findings suggest differing chronic lung diseases are associated with varying risk factors among COVID-19 patients.
July 07, 2020
There is also an association between late onset of spring and an increase in hospital admissions for asthma.
July 02, 2020
ADHD, autism spectrum disorder, seizures, and even developmental delays are asssociated with a two-fold risk of asthma in US children.
June 19, 2020
The FDA is allowing the pen to be used for the treatment of atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyposis (CRSwNP) patients at least 12 years old.